Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.
The Nutshell
Daily News Roundup
Most Recent
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.
Australian trout are susceptible to skin cancer, according to a new study—the first evidence that wild fish can be afflicted by the disease.
An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.
The first full computer model of a single-celled organism mimics the bacterium’s behaviors and paves the way to more complete disease models.
A trial comparing the effectiveness of robotic surgery and radiation for the treatment of throat cancer has begun in Canada.
Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
A public interest legal group has renewed the fight against DNA patenting.
Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
